6th Annual GCC Innovative Drug Discovery and Development Conference:
Pioneering New Approaches for Healthcare Innovation
May 6-7, 2025
Confirmed Keynote prenseters:
Michelle Arkin
Univ. of California, San Francisco
Miguel Hernán
Harvard Univ.
Other confirmed presenters include:
Bissan Al-Lazikani
MD Anderson Cancer Center
Zhiqiang An
Univ. of Texas Health Science Center, Houston
Cheryl Beal Anderson
ACE Regulatory Affairs Consulting
Chen-Ni Chin
Rock BioTherapeutics
Lynda Chin
Apricity Health, Inc.
Kevin Coker
MD Anderson Cancer Center
Kevin Dalby
Univ. of Texas
Siddhartha De
7 Hills Pharma Inc.
Abbas Dhilawala
Galen Data
Long Doan
SpyGlass Pharma Inc.
Dillon Fritz
GCC Research Evaluation and Commercialization Hub
Matthew Gibson
Hogan Lovells
Mohammad Ghasemi Rad
Baylor College of Medicine
George Golovok
Univ. of Texas Medical Branch, Galveston
Gabrielle Guttman
TMC Venture Fund
Zach Hightower
Portal Innovation
Recursion Pharmaceutical
Wissam Khalife
Univ. of Texas Medical Branch Galveston
Onur Kilic
Bairitone Health
Jeffrey Larson
Tvardi Therapeutics
Elaine Lea-Chou
ELC Private Consulting
Dong Liang
Texas Southern Univ.
Megan Liles
HGI Clinical Solutions
Qingyun “Jim” Liu
Univ. of Texas Health Science Center, Houston
David Maxwell
MD Anderson Cancer Center
Jennifer Maynard
Univ. of Texas
Stanton McHardy
Univ. of Texas at San Antonio
Deepak Nijhawan
Univ. of Texas Southwestern
Meagan Pitcher
Bairitone Health
Reid T. Powell
Texas A&M Univ.
Allison Rhines
Johnson & Johnson Innovation, JLABS TMC
Jennifer Roohi
TMC Innovation
Sandra Saldana
Alva Health
Supriya Sinha
Texas Medical Center Innovation
Clifford Stephan
Texas A&M Institute of Bioscience and Technology
Colby Suire
K2bio
Will Tankersley
Levit Green
Lacey Tezino
GCC Research Evaluation and Commercialization Hub
Suzanne Tomlinson-Mathis
GCC IDDD Core Network
Atul Varadhachary
Fannin Innovation
Jeffery Wade
BioHouston
Silver Sponsors
Bronze Sponsors
